{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:30:03Z","timestamp":1791531003869,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T00:00:00Z","timestamp":1472256000000},"content-version":"vor","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012728","name":"Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.cell.2015.07.043","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T14:24:05Z","timestamp":1439475845000},"page":"1090-1100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":381,"title":["Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site"],"prefix":"10.1016","volume":"162","author":[{"given":"Masaru","family":"Kanekiyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u00a0Gordon","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James\u00a0R.R.","family":"Whittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Baxa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Narpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Paul","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas\u00a0S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian\u00a0B.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard\u00a0A.","family":"Koup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael\u00a0G.","family":"Rossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John\u00a0R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney\u00a0S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey\u00a0I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary\u00a0J.","family":"Nabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2015.07.043_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.immunol.15.1.235","article-title":"Neutralizing antiviral B cell responses","volume":"15","author":"Bachmann","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cell.2015.07.043_bib2","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1126\/science.276.5321.2024","article-title":"The role of antibody concentration and avidity in antiviral protection","volume":"276","author":"Bachmann","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cell.2015.07.043_bib3","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/nprot.2010.126","article-title":"Cryo-EM of macromolecular assemblies at near-atomic resolution","volume":"5","author":"Baker","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cell.2015.07.043_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-1119(95)00149-Z","article-title":"Selection of recombinant vaccinia viruses on the basis of plaque formation","volume":"158","author":"Blasco","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.cell.2015.07.043_bib5","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1128\/JVI.00906-07","article-title":"Characterization of chimpanzee\/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in\u00a0vitro and in a vaccinia virus mouse protection model","volume":"81","author":"Chen","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib6","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1128\/JVI.02553-10","article-title":"Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis","volume":"85","author":"Chen","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib7","doi-asserted-by":"crossref","first-page":"20242","DOI":"10.1073\/pnas.1320041110","article-title":"Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor","volume":"110","author":"Chen","year":"2013","journal-title":"Proc. Natl. Acad. Sci USA"},{"key":"10.1016\/j.cell.2015.07.043_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jmb.2009.04.078","article-title":"The crystal structure of ferritin from Helicobacter pylori reveals unusual conformational changes for iron uptake","volume":"390","author":"Cho","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.cell.2015.07.043_bib9","doi-asserted-by":"crossref","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2015.07.043_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrmicro2548","article-title":"Fusing structure and function: a structural view of the herpesvirus entry machinery","volume":"9","author":"Connolly","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cell.2015.07.043_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2015.07.043_bib12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus Particles in Cultured Lymphoblasts from Burkitt\u2019s Lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2015.07.043_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/318287a0","article-title":"Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine","volume":"318","author":"Epstein","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.cell.2015.07.043_bib15","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","article-title":"Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2","volume":"81","author":"Fingeroth","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2015.07.043_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/COH.0b013e328363a90e","article-title":"Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site","volume":"8","author":"Georgiev","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.cell.2015.07.043_bib17","first-page":"171","article-title":"First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen","volume":"84","author":"Gu","year":"1995","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.cell.2015.07.043_bib18","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.77.5.2979","article-title":"Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen","volume":"77","author":"Hoffman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2015.07.043_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nchembio.1163","article-title":"Re-engineering protein interfaces yields copper-inducible ferritin cage assembly","volume":"9","author":"Huard","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2015.07.043_bib20","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.00445-07","article-title":"Epstein-Barr virus entry","volume":"81","author":"Hutt-Fletcher","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nmat3775","article-title":"Engineering synthetic vaccines using cues from natural immunity","volume":"12","author":"Irvine","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.cell.2015.07.043_bib22","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/smll.200700011","article-title":"Production of apoferritin-based bioinorganic hybrid nanoparticles by bacterial fermentation followed by self-assembly","volume":"3","author":"J\u00e4\u00e4skel\u00e4inen","year":"2007","journal-title":"Small"},{"key":"10.1016\/j.cell.2015.07.043_bib23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cell.2015.07.043_bib24","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/JVI.02717-12","article-title":"Outer domain of HIV-1 gp120: antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04","volume":"87","author":"Joyce","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/imr.12005","article-title":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA","volume":"250","author":"Julien","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cell.2015.07.043_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2015.07.043_bib27","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2015.07.043_bib28","doi-asserted-by":"crossref","first-page":"e1003364","DOI":"10.1371\/journal.ppat.1003364","article-title":"Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape","volume":"9","author":"Krey","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2015.07.043_bib29","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.1212371109","article-title":"Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2015.07.043_bib30","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1107\/S0907444913016776","article-title":"Structural basis for the antibody neutralization of herpes simplex virus","volume":"69","author":"Lee","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2015.07.043_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/ind.2006.2.143","article-title":"Ferritin nanoparticle technology. A new platform for antigen presentation and vaccine development","volume":"2","author":"Li","year":"2006","journal-title":"Ind. Biotechnol."},{"key":"10.1016\/j.cell.2015.07.043_bib32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature11371","article-title":"Structural and genetic basis for development of broadly neutralizing influenza antibodies","volume":"489","author":"Lingwood","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2015.07.043_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-1759(84)90093-0","article-title":"A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens","volume":"67","author":"Luka","year":"1984","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cell.2015.07.043_bib34","doi-asserted-by":"crossref","first-page":"e1002387","DOI":"10.1371\/journal.ppat.1002387","article-title":"Antibody evasion by a gammaherpesvirus O-glycan shield","volume":"7","author":"Machiels","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2015.07.043_bib35","first-page":"3","article-title":"Mid Staffordshire inquiry. Too long, too late but Francis can still help make the NHS better","volume":"123","author":"McLellan","year":"2013","journal-title":"Health Serv. J."},{"key":"10.1016\/j.cell.2015.07.043_bib36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1126\/science.1636086","article-title":"Magnetoferritin: in\u00a0vitro synthesis of a novel magnetic protein","volume":"257","author":"Meldrum","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.cell.2015.07.043_bib37","doi-asserted-by":"crossref","first-page":"12523","DOI":"10.1128\/JVI.01822-13","article-title":"The structure and host entry of an invertebrate parvovirus","volume":"87","author":"Meng","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib38","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","article-title":"Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults","volume":"25","author":"Moutschen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2015.07.043_bib39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.celrep.2013.01.023","article-title":"Human complement receptor type 1\/CD35 is an Epstein-Barr Virus receptor","volume":"3","author":"Ogembo","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2015.07.043_bib40","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/jvi.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/jsbi.2002.4435","article-title":"Combining electron microscopic with x-ray crystallographic structures","volume":"136","author":"Rossmann","year":"2001","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.cell.2015.07.043_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2009.06.013","article-title":"Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay","volume":"391","author":"Sashihara","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.cell.2015.07.043_bib43","doi-asserted-by":"crossref","first-page":"e1002308","DOI":"10.1371\/journal.ppat.1002308","article-title":"Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge","volume":"7","author":"Sashihara","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2015.07.043_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0042-6822(89)90345-0","article-title":"Characterization of N- and O-linked oligosaccharides of glycoprotein 350 from Epstein-Barr virus","volume":"170","author":"Serafini-Cessi","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.cell.2015.07.043_bib45","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2015.07.043_bib46","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nsmb.1473","article-title":"Structural basis of enzyme encapsulation into a bacterial nanocompartment","volume":"15","author":"Sutter","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2015.07.043_bib47","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nsmb1161","article-title":"Structure of the Epstein-Barr virus major envelope glycoprotein","volume":"13","author":"Szakonyi","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2015.07.043_bib48","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1128\/jvi.62.12.4452-4464.1988","article-title":"Soluble gp350\/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes","volume":"62","author":"Tanner","year":"1988","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib49","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1073\/pnas.77.9.5307","article-title":"Monoclonal antibodies against the major glycoprotein (gp350\/220) of Epstein-Barr virus neutralize infectivity","volume":"77","author":"Thorley-Lawson","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2015.07.043_bib50","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/jvi.43.2.730-736.1982","article-title":"Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in\u00a0vivo","volume":"43","author":"Thorley-Lawson","year":"1982","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1006\/jmbi.1995.0274","article-title":"High resolution crystal structures of amphibian red-cell L ferritin: potential roles for structural plasticity and solvation in function","volume":"248","author":"Trikha","year":"1995","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.cell.2015.07.043_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm830","article-title":"Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells","volume":"9","author":"Tugizov","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2015.07.043_bib53","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1128\/JVI.79.3.1635-1644.2005","article-title":"Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus","volume":"79","author":"van den Brink","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib54","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1107\/S0907444906018294","article-title":"Structure of human ferritin L chain","volume":"62","author":"Wang","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2015.07.043_bib55","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly\u00a0neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2015.07.043_bib56","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cell.2015.07.043_bib57","doi-asserted-by":"crossref","first-page":"11217","DOI":"10.1128\/JVI.01673-08","article-title":"Molecular basis of the interaction between complement receptor type 2 (CR2\/CD21) and Epstein-Barr virus glycoprotein gp350","volume":"82","author":"Young","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2015.07.043_bib58","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"Zhou","year":"2010","journal-title":"Science"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867415009599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867415009599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T03:43:27Z","timestamp":1638675807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867415009599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0092867415009599"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2015.07.043","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2015.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}